Potential conflict of interest: Nothing to report.
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies
Version of Record online: 7 AUG 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 58, Issue 5, pages 1587–1597, November 2013
How to Cite
Pedersen, J., Carlsen, T. H.R., Prentoe, J., Ramirez, S., Jensen, T. B., Forns, X., Alter, H., Foung, S. K.H., Law, M., Gottwein, J., Weis, N. and Bukh, J. (2013), Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies. Hepatology, 58: 1587–1597. doi: 10.1002/hep.26524
This work was supported by the Lundbeck Foundation (to J.G. and J.B.), the Danish Cancer Society (to J.G. and J.B.), the Novo Nordisk Foundation (to J.G. and J.B.), the RegionH Research Fund (to J.B.), The Danish Agency for Science Technology and Innovation (to J.P. and N.W.), and Ph.D. stipends from the Faculty of Health and Medical Sciences, University of Copenhagen (to T.H.R.C., J.P.R., and T.B.J.). J.P.R. and S.R. are the recipients of Individual Postdoctoral Stipends from the Danish Council for Independent Research (FSS). M.L. is supported by the U.S. National Institutes of Health (grant no.: AI79031).
GenBank accession numbers: T9/JFH1: KC967476; DH8/JFH1: KC967477; DH10/JFH1: KC967478; and S83/JFH1: KC967479.
- Issue online: 30 OCT 2013
- Version of Record online: 7 AUG 2013
- Accepted manuscript online: 31 MAY 2013 08:43AM EST
- Manuscript Accepted: 10 MAY 2013
- Manuscript Received: 14 MAR 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.